News

The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins.

Diaclone has been interested for many years in adhesion molecules and can provide monoclonal antibodies against all of the selectin and integrin families, most of the IgSF CAM family and also EpCAM, H-CAM, M-CAM and BL-CAM.

These monoclonal antibodies include, amongst others, Anti-Human CD31, CD50, CD54, CD66a, CD102, CD106, CD62…

Knowing that the soluble form levels could become an innovative tool of cancer monitoring, Diaclone has also developed ELISA kits for measuring serum levels of a wide range of sCAMs:

I-CAM-1 (human CD54 ELISA kit), I-CAM-2 (human CD102 ELISA kit), I-CAM-3 (human CD50 ELISA kit), VCAM-1 (human CD106 ELISA kit), PECAM-1 (CD31 ELISA kit), …

Find out more...

 

 

 

Other news

• 

  Our experience and innovation at your service.... Read more

• 

  Come and meet us at the second edition of Innovative Therapies Days in Besançon on the 20th and 21st of September. Read more

• 

  Medix Biochemica broadens its capabilities in diagnostic base matrices through the acquisition of Bioresource Technology Read more

• 

  Important news concerning our CE Marked product range... Read more

• 

  We provide a wide selection of SARS-CoV-2 antibodies and recombinant proteins to support COVID-19 related assay development. We are actively working to develop a recombinant SARS-CoV-2 Spike RBD Omicron variant protein and it will be available very soon! Read more

• 

  Our SARS-CoV-2 product range is extended with three anti-RBD (spike protein) "B-" Clones : B-B60, B-D69 and B-R41 Read more

• 

  Click and discover what's new... Read more

• 

  Developed in our laboratories in Besançon (France) #715-H25-0BU SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2 Read more

• 

  Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology and immunology. Read more

• 

  Our BEST SELLER the IFNγ ELISpot assay, is widely used in clinical cancer studies and also in COVID-19 research Read more

• 

  The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT Read more

• 

  Diaclone and Seed Biosciences collaborate on the development of a new workflow for a faster and more efficient antibody development process Read more

• 

  Developed in our laboratories in Besançon (France) Read more

• 

  Ideal for your COVID-19 studies... Read more

• 

  Discover our new IL1RAP clones... Read more

• 

  Essential tools for Cytokine Storm monitoring & Immunotherapy development... Read more

• 

  Diaclone provides a large panel of research tools, Monoclonal Antibodies and Immunoassays, for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome - CRS), including a complete range of human IL-6 and TNF-α products. Read more

• 

  DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines. Read more

• 

  C'était il y a 30 ans.... Read more

• 

  In vitro studies with Diaclone’s Toolbox to monitor the risks linked to immunotherapy.... Read more

• 

  Our Monoclonal Antibodies and ELISpot range are valuable tools for your CAR-T research. Read more

• 

  The Octet technology is fully integrated into our custom monoclonal antibody development so that it can be implemented to further study monoclonal antibody candidates. Read more

• 

  How can Diaclone support your CAR-T development? Read more

• 

  Diaclone is a partner in a major European project involving a dozen partners from the Besançon region. Read more

• 

  Diaclone has developed a large range of ELISA and ELISpot kits for the detection of Human IL-17A, IL-17F and IL-17A/F. Read more